Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Thoughts about using Fecal transplant as a treatment option for recurrent difficult to treat C diff infection in an elderly kidney transplant patient.
Related Questions
How do you approach kidney transplant evaluation and management in an ESKD patient with a history of anti-GBM disease and currently detectable anti-GBM antibodies?
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
Would you refer a patient for kidney only or kidney and liver transplantation if they develop advanced chronic kidney disease secondary to primary hyperoxaluria type 2?
Would you recommend routinely checking ANCA levels just prior to a planned kidney transplantation in patients with a history of ESKD secondary to ANCA-associated vasculitis?
How do you approach the decision to perform preimplantation biopsies in brain-dead kidney donors?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
Do you recommend 24 hour urine stone risk studies for patients with no history of nephrolithiasis who are undergoing evaluation as potential kidney donors?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
